On April 12, 2023, Denovicon Therapeutics Founder & CEO, Scott Bembenek, will present on ‘Enhanced Active Learning by Combining Machine Learning and Structure-Based Methods’ at the Drug Discovery Chemistry Conference: Artificial Intelligence for Early Drug Discovery – Part 2 in San Diego, CA.
858-692-3573
info@denovicontx.com
